| Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons AC Scallet, LC Schmued, W Slikker Jr, N Grunberg, PJ Faustino, H Davis, ... Toxicological sciences 81 (2), 364-370, 2004 | 363 | 2004 |
| Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. PF Daly, RC Lyon, PJ Faustino, JS Cohen Journal of Biological Chemistry 262 (31), 14875-14878, 1987 | 336 | 1987 |
| Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy. PC Van Zijl, CT Moonen, P Faustino, J Pekar, O Kaplan, JS Cohen Proceedings of the National Academy of Sciences 88 (8), 3228-3232, 1991 | 276 | 1991 |
| Summary workshop report: biopharmaceutics classification system—implementation challenges and extension opportunities JE Polli, XY Lawrence, JA Cook, GL Amidon, RT Borchardt, BA Burnside, ... Journal of pharmaceutical sciences 93 (6), 1375-1381, 2004 | 168 | 2004 |
| Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate D Awotwe-Otoo, C Agarabi, PJ Faustino, MJ Habib, S Lee, MA Khan, ... Journal of pharmaceutical and biomedical analysis 62, 61-67, 2012 | 159 | 2012 |
| Tissue distribution and stability of metalloporphyrin MRI contrast agents RC Lyon, PJ Faustino, JS Cohen, A Katz, F Mornex, D Colcher, C Baglin, ... Magnetic resonance in medicine 4 (1), 24-33, 1987 | 157 | 1987 |
| Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism O Kaplan, G Navon, RC Lyon, PJ Faustino, EJ Straka, JS Cohen Cancer research 50 (3), 544-551, 1990 | 150 | 1990 |
| Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy RC Lyon, JS Cohen, PJ Faustino, F Megnin, CE Myers Cancer research 48 (4), 870-877, 1988 | 147 | 1988 |
| Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue PJ Faustino, Y Yang, JJ Progar, CR Brownell, N Sadrieh, JC May, ... Journal of pharmaceutical and biomedical analysis 47 (1), 114-125, 2008 | 142 | 2008 |
| Differences in Phosphate Metabolite Levels in Drug-sensitive and -resistant Human Breast Cancer Cell Lines Determined by 31P Magnetic Resonance Spectroscopy JS Cohen, RC Lyon, C Chen, PJ Faustino, G Batist, M Shoemaker, ... Cancer Research 46 (8), 4087-4090, 1986 | 127 | 1986 |
| Biopharmaceutics classification of selected β-blockers: solubility and permeability class membership Y Yang, PJ Faustino, DA Volpe, CD Ellison, RC Lyon, LX Yu Molecular pharmaceutics 4 (4), 608-614, 2007 | 106 | 2007 |
| A modern view of excipient effects on bioequivalence: case study of sorbitol ML Chen, AB Straughn, N Sadrieh, M Meyer, PJ Faustino, AB Ciavarella, ... Pharmaceutical research 24, 73-80, 2007 | 101 | 2007 |
| Quantitative measurement of cyanide released from Prussian Blue Y Yang, C Brownell, N Sadrieh, J May, A Del Grosso, D Place, ... Clinical Toxicology 45 (7), 776-781, 2007 | 86 | 2007 |
| Classification of drug permeability with a Caco-2 cell monolayer assay DA Volpe, PJ Faustino, AB Ciavarella, EB Asafu-Adjaye, CD Ellison, ... Clinical Research and Regulatory Affairs 24 (1), 39-47, 2007 | 84 | 2007 |
| Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products AB Ciavarella, A Gupta, VA Sayeed, MA Khan, PJ Faustino Journal of pharmaceutical and biomedical analysis 43 (5), 1647-1653, 2007 | 83 | 2007 |
| Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine EB Asafu-Adjaye, PJ Faustino, MA Tawakkul, LW Anderson, XY Lawrence, ... Journal of pharmaceutical and biomedical analysis 43 (5), 1854-1859, 2007 | 79 | 2007 |
| Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cells F Megnin, PJ Faustino, RC Lyon, PI Lelkes, JS Cohen Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 929 (2), 173-181, 1987 | 71 | 1987 |
| Participation of women in clinical trials for new drugs approved by the Food and Drug Administration in 2000–2002 Y Yang, AS Carlin, PJ Faustino, MIP Motta, ML Hamad, R He, Y Watanuki, ... Journal of Women's Health 18 (3), 303-310, 2009 | 69 | 2009 |
| Quantitative molecular analysis with molecular bands emission using laser-induced breakdown spectroscopy and chemometrics FR Doucet, PJ Faustino, M Sabsabi, RC Lyon Journal of Analytical Atomic Spectrometry 23 (5), 694-701, 2008 | 67 | 2008 |
| Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines Z Yang, PJ Faustino, PA Andrews, R Monastra, AA Rasmussen, ... Cancer chemotherapy and pharmacology 46, 255-262, 2000 | 66 | 2000 |
